GE Healthcare Life Sciences Hosts Graduate Students from Japan - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

GE Healthcare Life Sciences Hosts Graduate Students from Japan



GE Healthcare Life Sciences has formed a joint program with Osaka University to offer students access to GE Healthcare’s training and technologies for biopharmaceutical research and manufacturing, to help support future growth of the sector in Japan.  The program, Interdisciplinary Program for Biomedical Sciences (IPBS), is Osaka University’s government-funded commitment to graduate education, which aligns with GE Healthcare Japan’s “Life Sciences Academy,” a GE Healthcare initiative launched in April 2013 with the objective of supporting the development of life sciences researchers in Japan.  Of the 14 IPBS graduate students, four will visit GE Healthcare Life Science’s Uppsala site for three weeks.

While at GE Healthcare in Uppsala, the Osaka University students will experience life in an R&D laboratory, closely working with GE Healthcare scientists and engineers. The students will receive comprehensive training in GE Healthcare’s advanced bioprocessing technologies and gain experience of protein interaction analysis and laboratory-scale protein purification using GE Healthcare instruments including Biacore and MicroCal systems for label-free analyses and ÄKTA pure chromatography systems.

Source: GE Healthcare Life Sciences

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here